{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:12:15Z","timestamp":1783480335937,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004681","name":"Higher Education Commission Pakistan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004681","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ijbiomac.2024.131268","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T08:35:42Z","timestamp":1712219742000},"page":"131268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"P1","title":["Identification, crystallization, and first X-ray structure analyses of phenyl boronic acid-based inhibitors of human carbonic anhydrase-II"],"prefix":"10.1016","volume":"267","author":[{"given":"Saima","family":"Rasheed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor ul","family":"Huda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Zo\u00eb","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Falke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik Shoaib","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Iqbal","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ijbiomac.2024.131268_bb0005","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/17460441.2020.1743676","article-title":"Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery","volume":"15","author":"Supuran","year":"2020","journal-title":"Expert Opin. Drug Discovery"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.131268_bb0010","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1016\/S0021-9258(17)40334-6","article-title":"Carbonic anhydrase activity in intact red blood cells measured with 18O exchange","volume":"252","author":"Itada","year":"1977","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.131268_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/jmr.3063","article-title":"Carbonic anhydrase inhibition by antiviral drugs in vitro and in silico","volume":"36","author":"T\u00fcrke\u015f","year":"2023","journal-title":"J. Mol. Recognit."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.131268_bb0020","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/med.21713","article-title":"Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: where are we today?","volume":"40","author":"Mishra","year":"2020","journal-title":"Med. Res. Rev."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.131268_bb0025","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1016\/S0021-9258(17)40334-6","article-title":"Carbonic anhydrase activity in intact red blood cells measured with 18O exchange","volume":"252","author":"Itada","year":"1977","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.131268_bb0030","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/med.21713","article-title":"Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: where are we today?","volume":"40","author":"Mishra","year":"2020","journal-title":"Med. Res. Rev."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.131268_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200132","article-title":"Design, synthesis, and biological activity of novel dithiocarbamate-methylsulfonyl hybrids as carbonic anhydrase inhibitors","volume":"355","author":"Osmaniye","year":"2022","journal-title":"Arch. Pharm."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131268_bb0040","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131268_bb0045","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/14756366.2014.913587","article-title":"Recent advances in the discovery of zinc-binding motifs for the development of carbonic anhydrase inhibitors","volume":"30","author":"Winum","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131268_bb0050","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1021\/jm301625s","article-title":"Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): A class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases","volume":"56","author":"Tars","year":"2013","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131268_bb0055","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/acs.jmedchem.5b01720","article-title":"Thioxocoumarins show an alternative carbonic anhydrase inhibition mechanism compared to coumarins","volume":"59","author":"Ferraroni","year":"2016","journal-title":"J. Med. Chem."},{"issue":"18","key":"10.1016\/j.ijbiomac.2024.131268_bb0060","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1016\/j.bmcl.2012.07.094","article-title":"Inhibition of \u03b1-class cytosolic human carbonic anhydrases I, II, IX and XII, and \u03b2-class fungal enzymes by carboxylic acids and their derivatives: new isoform-I selective nanomolar inhibitors","volume":"22","author":"Sechi","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.131268_bb0065","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1021\/acs.jmedchem.6b00462","article-title":"Monothiocarbamates strongly inhibit carbonic anhydrases in vitro and possess intraocular pressure lowering activity in an animal model of glaucoma","volume":"59","author":"Vullo","year":"2016","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.ijbiomac.2024.131268_bb0070","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1039\/c2cc16395k","article-title":"Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations","volume":"48","author":"Carta","year":"2012","journal-title":"Chemical Communications"},{"issue":"70","key":"10.1016\/j.ijbiomac.2024.131268_bb0075","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.1039\/c2cc34275h","article-title":"Hydroxamate represents a versatile zinc binding group for the development of new carbonic anhydrase inhibitors","volume":"48","author":"Di Fiore","year":"2012","journal-title":"Chem. Commun."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.131268_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900383","article-title":"Sulfonamides incorporating ketene N, S-acetal bioisosteres as potent carbonic anhydrase and acetylcholinesterase inhibitors","volume":"353","author":"Istrefi","year":"2020","journal-title":"Arch. Pharm."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.131268_bb0085","article-title":"Design, synthesis, and biological activity of novel dithiocarbamate-methylsulfonyl hybrids as carbonic anhydrase inhibitors","volume":"355","author":"T\u00fcrke\u015f","year":"2022","journal-title":"Arch. Pharm."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.131268_bb0090","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/17460441.2020.1743676","article-title":"Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery","volume":"15","author":"Supuran","year":"2020","journal-title":"Expert Opin. Drug Discovery"},{"key":"10.1016\/j.ijbiomac.2024.131268_bb0095","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ejmech.2019.06.092","article-title":"Boron in drug design: recent advances in the development of new therapeutic agents","volume":"179","author":"Fernandes","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131268_bb0100","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/med.10043","article-title":"Boronic acid compounds as potential pharmaceutical agents","volume":"23","author":"Yang","year":"2003","journal-title":"Med. Res. Rev."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.131268_bb0105","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.4155\/fmc.09.71","article-title":"Therapeutic potential of boron-containing compounds","volume":"1","author":"Baker","year":"2009","journal-title":"Future Med. Chem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.131268_bb0110","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00045391-200109000-00005","article-title":"Boron therapeutics on the horizon","volume":"8","author":"Groziak","year":"2001","journal-title":"Am. J. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131268_bb0115","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1080\/14756366.2022.2072837","article-title":"The inhibitory effect of boric acid on hypoxia-regulated tumour-associated carbonic anhydrase IX","volume":"37","author":"Yusuf","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.131268_bb0120","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1016\/j.bmc.2009.03.058","article-title":"Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isoforms I and II and transmembrane, tumor-associated isoforms IX and XII with boronic acids","volume":"17","author":"Winum","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.131268_bb0125","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.bmcl.2009.03.147","article-title":"Carbonic anhydrase inhibitors. Inhibition of the fungal \u03b2-carbonic anhydrases from Candida albicans and Cryptococcus neoformans with boronic acids","volume":"19","author":"Innocenti","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"80","key":"10.1016\/j.ijbiomac.2024.131268_bb0130","doi-asserted-by":"crossref","first-page":"11983","DOI":"10.1039\/C6CC06399C","article-title":"Benzoxaborole as a new chemotype for carbonic anhydrase inhibition","volume":"52","author":"Di\u00e1Fiore","year":"2016","journal-title":"Chem. Commun."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.131268_bb0135","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1021\/acsmedchemlett.9b00252","article-title":"Bis-benzoxaboroles: design, synthesis, and sssbiological evaluation as carbonic anhydrase inhibitors","volume":"10","author":"Larcher","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.131268_bb0140","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1107\/S2052252516010514","article-title":"Neutron structure of human carbonic anhydrase II in complex with methazolamide: mapping the solvent and hydrogen-bonding patterns of an effective clinical drug","volume":"3","author":"Aggarwal","year":"2016","journal-title":"IUCrJ"},{"issue":"2\u20133","key":"10.1016\/j.ijbiomac.2024.131268_bb0145","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.eplepsyres.2005.01.001","article-title":"Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase","volume":"63","author":"Shank","year":"2005","journal-title":"Epilepsy Res."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.131268_bb0150","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1107\/S1744309106020446","article-title":"X-ray crystallographic studies reveal that the incorporation of spacer groups in carbonic anhydrase inhibitors causes alternate binding modes","volume":"62","author":"Fisher","year":"2006","journal-title":"Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.131268_bb0155","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1107\/S090744491003982X","article-title":"An introduction to data reduction: space-group determination, scaling and intensity statistics","volume":"67","author":"Evans","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131268_bb0160","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1107\/S0907444909042589","article-title":"Molecular replacement with MOLREP","volume":"66","author":"Vagin","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131268_bb0165","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1107\/S2059798317016035","article-title":"CCP4i2: the new graphical user interface to the CCP4 program suite","volume":"74","author":"Potterton","year":"2018","journal-title":"Acta Crystallographica Section D: Structural Biology"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.131268_bb0170","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1107\/S0907444911001314","article-title":"REFMAC5 for the refinement of macromolecular crystal structures","volume":"67","author":"Murshudov","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.131268_bb0175","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2024.131268_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105009","article-title":"Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo [2, 1-b][1, 3, 4] thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors","volume":"113","author":"Askin","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2024.131268_bb0185","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/bcpt.12790","article-title":"Human BJ fibroblasts is an alternative to mouse BALB\/c 3T3 cells in in vitro neutral red uptake assay","volume":"121","author":"Mannerstr\u00f6m","year":"2017","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.131268_bb0190","first-page":"1392","article-title":"Use of the tetrazolium assay in measuring the response of human tumor cells to ionizing radiation","volume":"50","author":"Price","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2024.131268_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124232","article-title":"Discovery of novel benzenesulfonamides incorporating 1, 2, 3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors","volume":"239","author":"Buza","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.131268_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.117111","article-title":"Exploration of 1, 2, 3-triazole linked benzenesulfonamide derivatives as isoform selective inhibitors of human carbonic anhydrase","volume":"77","author":"Kakakhan","year":"2023","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.131268_bb0205","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S2052252514009324","article-title":"The PDB_REDO server for macromolecular structure model optimization","volume":"1","author":"Joosten","year":"2014","journal-title":"IUCrJ"},{"key":"10.1016\/j.ijbiomac.2024.131268_bb0210","series-title":"The PyMOL Molecular Graphics System, Version 2.0","author":"Schr\u00f6dinger","year":"2020"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024020737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024020737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T11:06:59Z","timestamp":1718536019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024020737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":42,"alternative-id":["S0141813024020737"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131268","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification, crystallization, and first X-ray structure analyses of phenyl boronic acid-based inhibitors of human carbonic anhydrase-II","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131268","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"131268"}}